Form 8-K - Current report:
SEC Accession No. 0001140361-25-002461
Filing Date
2025-01-30
Accepted
2025-01-30 17:01:30
Documents
14
Period of Report
2025-01-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20042621_8k.htm   iXBRL 8-K 36673
2 EXHIBIT 99.1 ef20042621_ex99-1.htm EX-99.1 10437
  Complete submission text file 0001140361-25-002461.txt   187572

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cdmo-20250130.xsd EX-101.SCH 3979
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdmo-20250130_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdmo-20250130_pre.xml EX-101.PRE 16042
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20042621_8k_htm.xml XML 4059
Mailing Address 14191 MYFORD ROAD TUSTIN CA 92780
Business Address 14191 MYFORD ROAD TUSTIN CA 92780 714.508.6100
Avid Bioservices, Inc. (Filer) CIK: 0000704562 (see all company filings)

EIN.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 25574685
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)